GGrantIndex
Sort

85,873 grants matching alzheimers

ARMADA: Advancing Reliable Measurement in Alzheimer's Disease and cognitive Aging - Project Core

$1,531,313
Sandra Weintraub · Northwestern University At Chicago · U2C · FY2018 · AG

An Acquisition and Analysis Pipeline for Integrating MRI and Neuropathology in TBI-related Dementia and VCID

$1,531,181
Andre Jan Willem Van Der Kouwe · Massachusetts General Hospital · U24 · FY2024 · NS

IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.

$1,531,012
Kathleen E. Rodgers · University Of Arizona · U01 · FY2021 · AG

Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease

$1,530,945
Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AG

Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease

$1,530,583
Allan I Levey · Emory University · U01 · FY2014 · AG

Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel Disease

$1,530,150
Danny Jiong Jiong Wang · University Of Southern California · UH3 · FY2020 · NS

The Hospice Advanced dementia Symptom Management and Quality of Life Trial (HAS-QOL)

$1,529,695
Abraham Aizer Brody · New York University · R33 · FY2019 · AG

Impact of Depression on Alzheimer's disease: Prenatal Immune Origins and Shared Impact of Sex

$1,529,272
Jill M Goldstein · Massachusetts General Hospital · R01 · FY2022 · AG

Novel Mechanisms of NSAID Action in Alzheimer's Disease

$1,529,185
Edward H. Koo · University Of California, San Diego · P01 · FY2010 · AG

Neural Mechanisms Of Stimulus Memory And Habit Formation

$1,529,164
Mortimer Mishkin · National Institute Of Mental Health · ZIA · FY2011 · MH

Mechanisms Of Action Of Psychoactive Drugs

$1,528,755
De-Maw Chuang · National Institute Of Mental Health · ZIA · FY2010 · MH

IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.

$1,528,567
Kathleen E. Rodgers · University Of Arizona · U01 · FY2023 · AG

Protective roles of grape-derived polyphenols in Alzheimer's disease

$1,528,267
Giulio Maria Pasinetti · Icahn School Of Medicine At Mount Sinai · P01 · FY2011 · AT

Pharmacology Of Stimulus Memory And Habit Formation

$1,528,247
Mortimer Mishkin · National Institute Of Mental Health · ZIA · FY2011 · MH

Regional, Synaptic, Cellular Modulation of Abeta Metabolism

$1,528,223
David M Holtzman · Washington University · P01 · FY2017 · NS

Emory Alzheimer's Disease Center

$1,528,074
Allan I Levey · Emory University · P50 · FY2011 · AG

The Longitudinal Course O\F Imaging Biomarkers in People At RISK of AD

$1,527,464
Sterling C Johnson · University Of Wisconsin-Madison · R01 · FY2019 · AG

Epigenomic, transcriptional and cellular dissection of Alzheimer's variants

$1,527,396
Manolis Kellis · Broad Institute, Inc. · R01 · FY2017 · AG

p53, Aging, and Cancer

$1,527,281
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Dissecting signaling pathways and seeking EV phosphoproteins as novel biomarkers for Alzheimer's Disease

$1,526,896
W. Andy Tao · Purdue University · RF1 · FY2020 · AG

ESTROGEN AND THE AGING BRAIN

$1,526,690
Mount Sinai School Of Medicine Of Nyu · P01 · FY2001 · AG

Differential Effects of Exercise Modality on Cognition and Brain in Older Adults

$1,526,464
Eric Dennis Vidoni · University Of Kansas Medical Center · R01 · FY2022 · AG

Spatial-Temporal Characterization of The Hemodynamic Response to Neural Activity

$1,526,307
Afonso Silva · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS

Administrative Core

$1,526,250
Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · U19 · FY2025 · AG

Analytics Core

$1,526,248
Kwangsik Timothy Nho · Mayo Clinic Jacksonville · U19 · FY2025 · AG